MYDENTALWIG™: AN INTEGRATED TECHNOLOGY ECOSYSTEM
From the mouth to intelligence.
MYDENTALWIG is building a vertically integrated technology ecosystem connecting dental innovation, human health, EI (Extraordinary Intelligence), sensing, advanced manufacturing, and intelligent infrastructure — one continuous system, from the smile to the data center.
Please read “EI” – Extraordinary Intelligence – wherever “AI” appears in this website.
“Prevention Is Better Than Cure.”
Everything you need to know about the MYDENTALWIG™ ecosystem: the technology, the products, the business model, and the investment opportunity.
Who we are, what we are building, and why.
MYDENTALWIG is a U.S.-based technology development and advanced manufacturing company pursuing an integrated ecosystem spanning dental innovation, sensing technologies, intelligence software, semiconductor-related technologies, and manufacturing infrastructure.
Rather than focusing on a single product, our long-term strategy is to connect these capabilities within a coordinated business ecosystem.
Our mission is to develop intelligent, scalable, and resilient American manufacturing systems that connect healthcare, technology, and industrial capabilities.
Our guiding philosophy is: Prevention Is Better Than Cure.
We aim to apply this principle through research, technology development, responsible innovation, and the development of products intended to support human health.
Dental innovation remains an important part of our business. However, our strategic direction extends beyond traditional dental products.
We are developing a broader technology ecosystem that connects dental devices, intraoral sensing, intelligence systems, advanced manufacturing, semiconductor-related technologies, and supporting infrastructure.
Dental innovation is one entry point into this larger vision.
Our strategy emphasizes vertical integration: connecting intellectual property, research and development, product engineering, manufacturing, software, and potential commercial applications.
The objective is to develop complementary capabilities that may support multiple product categories and customer segments over time.
The successful execution of this strategy depends on funding, technical development, regulatory requirements, manufacturing readiness, and market adoption.
The seven connected domains, DCI™, EI²™, and where each product stands today.
Our ecosystem is organized around seven connected domains:
These domains represent a connected strategic vision. Their individual development, readiness, and commercialization timelines may differ.
DCI™ stands for Dental Computing Interface. It is a technology concept designed to connect data captured through dental or intraoral devices with downstream software and intelligence systems.
Its intended role is to help translate relevant biological or biomechanical signals into structured information for further analysis.
Specific capabilities depend on the technology developed, validated, and ultimately made available.
EI²™ stands for Extraordinary Ingestion Intelligence. It is MYDENTALWIG’s proposed intelligence platform for interpreting ingestion-related information and connecting relevant signals with analytical models and potential health-related applications.
The long-term objective is to integrate sensing, data processing, and intelligence into a connected system.
Performance, clinical usefulness, and any diagnostic or monitoring claims must be established through appropriate technical validation and, where applicable, clinical evidence and regulatory authorization.
DentalWig PLUS™ – Diabetes is a planned technology initiative intended to explore the integration of dental technology and ingestion-related intelligence for diabetes-related monitoring applications.
The initiative is part of the company’s broader development strategy. Its availability, final design, monitoring capabilities, clinical performance, and regulatory status depend on further development and applicable validation requirements.
It should not be considered a substitute for established diabetes monitoring or medical care.
Semiconductor-related technologies are part of the company’s broader strategic ambitions, including technologies intended to support sensing, connected devices, and advanced computing applications.
The company envisions expanding into advanced manufacturing capabilities as its technical and operational capacity develops.
Proposed manufacturing capacities, chip specifications, production volumes, and future sales are targets or projections where stated, not guarantees of completed facilities or commercial production.
Product availability varies by product and development stage.
Some offerings are in planning or development, while others may have separate ordering, waiting-list, or pre-order arrangements. For example, the current website identifies expected pre-orders for certain DentalWig products and the EI²™ PRO Diabetes Crown.
Please consult the official product page for the latest product-specific information, expected dates, pricing, and applicable terms.
A pre-order or projected launch date does not guarantee that a product will be delivered on a particular date.
How the ecosystem is designed to generate revenue and scale over time.
Our proposed business model includes multiple potential revenue streams, subject to development and commercial execution. These may include:
Not every business line is currently operational. Revenue timing and contribution will depend on product readiness, customer demand, financing, regulatory requirements, and execution.
Depending on the product or business line, intended customers may include consumers, dental professionals, healthcare organizations, research institutions, enterprise partners, manufacturers, and other commercial or institutional customers.
Different products may require different distribution channels, partnerships, regulatory pathways, and pricing models.
Vertical integration is intended to give the company greater coordination across research, product design, manufacturing, software, and commercialization.
The strategy may create opportunities to reuse technology and infrastructure across multiple applications, improve production coordination, and develop additional intellectual property.
However, vertical integration also requires substantial capital, specialized talent, effective management, and disciplined execution. Its anticipated benefits are not guaranteed.
The company intends to develop domestic manufacturing capabilities that can support dental innovation and potentially expand into additional advanced manufacturing and technology categories.
The strategy emphasizes research and development, production engineering, equipment, supplier development, workforce recruitment, and scalable operations.
The scope and timing of manufacturing expansion will depend on available funding, facility development, technical milestones, and commercial demand.
Our long-term vision is to build an integrated American technology ecosystem in which dental innovation, sensing, intelligence, manufacturing, and infrastructure reinforce one another.
The company may pursue additional complementary businesses as opportunities develop.
This is an ambitious, long-term strategy. Its realization depends on successful execution and should not be interpreted as a guarantee of future scale, profitability, or market leadership.
Offerings, eligibility, terms, and risks. Always verify against the current official offering documents.
Prospective investors should begin with the official investment information and the offering documents applicable to the specific investment opportunity.
Visit the MYDENTALWIG Investor Page or contact invest@mydentalwig.com to request information about the currently available offering.
Investment eligibility, minimum investment amounts, offering limits, and other terms depend on the particular offering and its governing documents.
Company materials have described different fundraising pathways, including Regulation Crowdfunding offerings and a separate Regulation D, Rule 506(c) financing opportunity for eligible accredited investors.
These are distinct legal offerings and may have different eligibility requirements, investment minimums, instruments, and terms.
Prospective investors must verify which offerings are currently open and review the applicable offering documents before making an investment. Information published for one offering should not automatically be applied to another.
SAFE stands for Simple Agreement for Future Equity. It is a contractual investment instrument that may provide a right to receive equity in the future when specified contractual conditions are met.
A SAFE is generally different from purchasing issued shares immediately. Its conversion mechanics, valuation cap, discount provisions, and other rights depend on the agreement.
Investors should read the complete SAFE and understand how conversion may work, what rights they receive, and what risks they assume before investing.
A valuation cap is a contractual term used in certain convertible financing instruments to determine how the conversion price may be calculated under specified circumstances.
It is not a guarantee that the company is currently worth $1 billion, that a future financing will occur at that valuation, or that an investor’s investment will appreciate to a particular value.
The economic effect of the cap depends on the complete agreement and future financing and conversion events.
Depending on the applicable offering, the company has described intended uses that may include hiring technical and operational personnel, research and development, engineering, supplier development, equipment and facilities, regulatory preparation, and commercialization.
The exact allocation of proceeds must be confirmed in the current offering documents.
Actual expenditures may differ from projections as business needs, development priorities, and financing conditions change.
Eligibility depends on the particular offering.
Regulation Crowdfunding and Regulation D, Rule 506(c), have different legal requirements and investor eligibility rules. For example, Rule 506(c) offerings are limited to verified accredited investors.
Prospective investors should confirm the requirements of the specific offering and complete any required identity, eligibility, and compliance verification.
Minimum investment amounts vary by offering and may change when offering terms are amended.
Please consult the current offering page and governing documents for the applicable minimum. Do not rely on an amount displayed in an older presentation, archived page, or materials for a different financing round.
Follow the instructions on the applicable official investment platform. Depending on the offering, the process may include:
Verification does not itself guarantee acceptance of an investment. The applicable offering terms and procedures govern the transaction.
Cancellation rights, deadlines, and refund procedures depend on the applicable offering, the stage of the transaction, and the governing agreements.
Investors should review the relevant documents carefully and contact the investment platform or company representative promptly if they have questions about cancellation.
Do not assume that an investment can be refunded after completion or that the same cancellation policy applies to every offering.
A future public listing has been described as a long-term objective. However, a public offering, direct listing, or other liquidity event is not guaranteed.
Any future listing would depend on business performance, market conditions, regulatory requirements, corporate readiness, and other factors.
Investors should not invest on the assumption that a public listing will occur or that it will provide liquidity at a particular time or valuation.
No. Dividends and investment returns are not guaranteed. Investors may earn a profit, receive dividends if declared, or lose some or all of their invested capital. Any dividends or distributions will depend on the company’s financial performance, applicable agreements, and other relevant factors.
The company is pursuing a development and growth strategy that involves significant uncertainty. Investors may lose some or all of their invested capital.
Any rights to distributions or other economic benefits depend on the investment instrument, governing agreements, applicable law, and the company’s future financial position.
Investing in an early-stage technology and manufacturing business involves substantial risks, including:
Prospective investors should carefully review the complete risk factors in the applicable offering documents and seek independent legal, financial, and tax advice as appropriate.
Start with the MYDENTALWIG Invest Page and the official offering documents linked there.
For applicable Regulation Crowdfunding offerings, review the relevant Form C or amended Form C and associated disclosures filed with the U.S. Securities and Exchange Commission: MYDENTALWIG’s Official Reg CF.
For other offerings, request the applicable private-placement or financing documents directly from the company.
Always confirm that the documents are current and correspond to the exact offering in which you are considering investing.
Collaborate with us, join the team, or reach the right person.
The company’s ecosystem strategy may create opportunities to work with technology developers, manufacturers, dental and healthcare professionals, research institutions, suppliers, and commercial partners.
Organizations interested in exploring a potential collaboration can contact the company with a description of their capabilities, proposed contribution, and areas of mutual interest.
Any partnership is subject to appropriate technical, commercial, legal, and operational evaluation.
The company’s development plans may require expertise in engineering, software, semiconductor technologies, manufacturing, research, clinical advisory work, operations, and commercialization.
For current openings and application instructions, visit Career Opportunities.
Available positions and hiring timelines depend on current business priorities and resources.
For general company information, product inquiries, and partnership opportunities, visit MYDENTALWIG.com.
For investment-related inquiries, email invest@mydentalwig.com.
Please specify the nature of your inquiry so it can be directed to the appropriate team.
The information presented on this page is intended for general informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Any investment offer may be made only through the applicable offering documents and in accordance with relevant securities laws.
Statements concerning future products, manufacturing capacity, revenue, market opportunities, financing, expansion, and potential public listings are forward-looking statements. Actual results may differ materially from current expectations.
Technology concepts, proposed product capabilities, development targets, and commercial plans may change. Health-related products and claims are subject to the evidence and regulatory requirements applicable to each product.
Investing in MYDENTALWIG involves risk, including the possible loss of all invested capital. Prospective investors should read all applicable disclosures and risk factors before making an investment decision.
From the mouth to intelligence. Explore the products, the science, and the systems behind MYDENTALWIG, or talk to the right team directly.
Investment inquiries: invest@mydentalwig.com
Subscribe to our newsletter and get the latest updates
Your Email Address
© Copyright by My Dental Wig